| Date | Acquired company | Acquiring company | Amount | Related |
|---|---|---|---|---|
| 2014-10-01 | consumer care business of Merck&Co (USA - NJ) | Bayer (Germany) | $14.2 billion (€10.4 billion) | OTC |
| 2014-10-01 | operation site in Terre Haute (USA - IN) | AmatsiGroup (France) | undisclosed | Technology - Services Veterinary medicine |
| 2014-09-30 | Alios Biopharma (USA - CA) | J&J (USA - NJ) | $1.75 billion (€1.37 billion) | Infectious diseases |
| 2014-09-29 | Sage Labs (USA - PA) | Horizon Discovery (UK) | up to $48 million (£29 million - €37.8 million) | Technology - Services |
| 2014-09-25 | InnoPharma (USA - NJ) | Pfizer (USA - NY) | up to $360 million (€265 million) | Generics Injectable |
| 2014-09-23 | Prestwick Chemical (France) | Bionomics (Australia) | €270,000 | Technology - Services |
| 2014-09-22 | Sigma-Aldrich (USA - MO) | Merck KGaA (Germany) | $17.0 billion (€13.1 billion) | Technology - Services |
| 2014-09-17 | generic injectables manufacturing site of Ben Venue Laboratories (USA - OH) , part of Boehringer Ingelheim (Germany) | Hikma Pharmaceuticals (UK) | undisclosed | Production Manufacturing |
| 2014-09-16 | Doliage (France) | Nicox (France) | € 5 million | Ophtalmological diseases |
| 2014-09-16 | Carragelose® anti-viral eye drop program owned by Marinomed Biotechnologie's subsidiary (Austria) | Nicox (France) | €2.65 million in newly issued Nicox shares and up to €2.65 million in potential additional cash payment | Ophtalmological diseases - Infectious diseases |
| 2014-09-11 | PharmEste\'s TRPA1 research assets (Italy) | Ario Pharma (UK) | undisclosed | Allergic diseases Respiratory diseases |
| 2014-09-11 | GE Healthcare’s FDG-PET Radiopharmaceutical Business in Italy | Advanced Accelerator Applications (France) | undisclosed | Molecular nuclear medicine Radiopharmaceuticals |
| 2014-09-10 | Diametra (Italy) | Immunodiagnostic Systems (UK) | undisclosed | diagnostic |
| 2014-09-04 | Cellectis AB (Sweden) | Takara Bio (Japan) | undisclosed | stem cells services |
| 2014-08-28 | Sapheon | Covidien (Ireland) | undisclosed | Cardiovascular diseases Medical devices |
| 2014-08-27 | manufacturing facility from Olympus Biotech (USA - NH) | Novo Nordisk (Denmark) | undisclosed | CMO production manufacturing |
| 2014-08-25 | Covagen (Switzerland) | Cilag GmBH, affiliate of Janssen Pharmaceuticals, a J&J company (USA - NJ) | undisclosed | |
| 2014-08-24 | Intermune (USA - CA) | Roche (Switzerland) | $ 8.3 billion (€6.26 billion) | Lung diseases Fibrotic diseases Respiratory diseases |
| 2014-08-22 | Reverse Medical Corporation (USA - CA) | Covidien (Ireland) | undisclosed | Medical devices Cardiovascular diseases |
| 2014-08-20 | Ethyol® (amifostine) from AstraZeneca (UK) | Clinigen (UK) | undisclosed |
